Profile
Antony J.
Fairbanks is the founder of GlycoForm Ltd.
founded in 2002.
He worked as a Faculty Member at the University of Oxford.
Dr. Fairbanks received his undergraduate and doctorate degrees from the University of Oxford in 1993.
Former positions of Antony J. Fairbanks
| Companies | Position | End |
|---|---|---|
GlycoForm Ltd.
 GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Founder | 2011-08-30 |
| University of Oxford | Corporate Officer/Principal | - |
Training of Antony J. Fairbanks
| University of Oxford | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Health Technology |
- Stock Market
- Insiders
- Antony J. Fairbanks